As a trusted leader in immunology, each new discovery gives us a better understanding of how patients are different - so we can develop more personalized approaches. More than 1 million people with immune-mediated diseases worldwide are treated with our therapies.
Elevating the standard of care by highlighting the mental, emotional and psychosocial impact of immune-mediated skin conditions.
How AbbVie is working to elevate the standards of care for patients with autoimmune diseases
Patients of color can face challenges when seeking care for skin conditions. See how we’re partnering with the dermatology community to help drive change.
Could precision medicine help immunology patients the way it has helped cancer patients?
A diagnosis at 13 years old, Marisa Troy’s life and her aspirations were greatly impacted by her IBD.
One person with psoriasis shares her journey — from childhood to working parent — and how her struggles with the disease have empowered her.
Science is working to uncover the roots of this serious inflammatory disease.
After a long journey to diagnosis, one patient finds strength in advocating for herself and others.
Creative problem solving and data-driven science helps researchers illuminate a smarter path toward compounds that may address unmet patient needs.
An invisible illness, Crohn’s disease impacts the patient and those closest to them. One patient shares how the love of her life helps her thrive every day.
How do new medicines originate? Meet the team behind early development of AbbVie’s immunology treatments.
Bruton’s tyrosine kinase helps immune function, but its malfunction may lead to cancer and autoimmune diseases. Scientists are researching new approaches in both areas.